Our work is powered by a toolkit of five R&D approaches – two established platforms (chemistry and biotherapeutics) plus three advanced platforms (xRNA, radioligand therapy and gene and cell therapy) that will play an increasingly important role in making new medicines.
We seek out new drug targets and design therapeutic interventions with the potential to treat diseases with high unmet needs.
Chemistry
The discovery of low weight synthetic molecules that can be optimized as medicines.
Biotherapeutics (biologics)
Medicines derived from molecules of life, carefully engineered to treat specific diseases.
xRNA
Therapies designed to block the production of disease-related proteins by targeting RNA.
Radioligand Therapy
A precision approach to delivering radiation directly to tumor cells while only minimally affecting surrounding healthy cells – almost like “a guided missile” to cancer cells.
Gene and cell therapy
Gene therapies modify part of a patient’s genes to help treat diseases, while cell therapy restores or alters certain cells or uses cells to carry a therapy in the body.